Steward Partners Investment Advisory’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Steward Partners Investment Advisory’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13	Closed	-$3	–	4160
2024 Q3	$3	Buy	+13	New	+$10	﹤0.01%	3737
2023 Q1	–	Sell	-150	Closed	-$403	–	3441
2022 Q4	$403	Hold	150	–	–	﹤0.01%	3212
2022 Q3	$1K	Hold	150	–	–	﹤0.01%	3188
2022 Q2	$2K	Hold	150	–	–	﹤0.01%	3054
2022 Q1	$2K	Buy	150 +100	+200%	+$1.73K	﹤0.01%	3133
2021 Q4	$1K	Buy	+50	New	+$1.18K	﹤0.01%	3142

Steward Partners Investment Advisory's BTCY Position: Q4 2024 in Review

Steward Partners Investment Advisory sold out of Biotricity, Inc. Common Stock (BTCY) in Q4 2024, closing a stake of 13 shares — an estimated $3 sold.

Steward Partners Investment Advisory first reported a position in BTCY in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold BTCY as of Q4 2024.

Steward Partners Investment Advisory reported no remaining Biotricity, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Steward Partners Investment Advisory sold 13 Biotricity, Inc. Common Stock shares in Q4 2024, an estimated $3.
Steward Partners Investment Advisory first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Steward Partners Investment Advisory's Biotricity, Inc. Common Stock position peaked at $2K in Q2 2022.
0 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q4 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2024, filed 6 Feb 2025.